The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. VYNE Therapeutics Inc’s current trading price is -66.15% away from its 52-week high, while its distance from the 52-week low is 1.08%. The stock’s price range for this period has been between $1.44 and $4.30 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 1.21 million for the day, a number notably higher than the average daily volume of 0.13 million over the last three months.
VYNE Therapeutics Inc experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $4.30 on 01/08/25, while the lowest price for the same period was registered at $1.44 on 04/25/25.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
VYNE Therapeutics Inc (VYNE) has experienced a quarterly decline of -47.26% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 22.13M and boasts a workforce of 13 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.3832, with a change in price of -1.5300. Similarly, VYNE Therapeutics Inc recorded 133,429 in trading volume during the last 100 days, posting a change of -51.86%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for VYNE stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
VYNE Stock Stochastic Average
VYNE Therapeutics Inc’s raw stochastic average for the past 50 days is presently 7.32%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 17.31%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 56.97% and 70.21%, respectively.
VYNE Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The index has shown a price loss of -56.55% this year. Over the last six months, there has been a stronger performance of -39.35%. The price of VYNE leaped by -14.88% during the last 30 days period. For the last 5-days stocks have slided -21.32%.
